Interleukin-17 in human inflammatory diseases

AG Shabgah, E Fattahi, FZ Shahneh - Advances in Dermatology and …, 2014 - termedia.pl
Human Th17 pro-inflammatory cells are currently defined as cells that produce IL-17A and F,
tumor necrosis factor (TNF)-α, IL-6, IL-21, IL-22 and IL-23. Recently discovered related …

Morphea and eosinophilic fasciitis: an update

JS Mertens, MMB Seyger, RM Thurlings… - American journal of …, 2017 - Springer
Morphea, also known as localized scleroderma, encompasses a group of idiopathic sclerotic
skin diseases. The spectrum ranges from relatively mild phenotypes, which generally cause …

Immunopathogenesis of pediatric localized scleroderma

KS Torok, SC Li, HM Jacobe, SF Taber… - Frontiers in …, 2019 - frontiersin.org
Localized scleroderma (LS) is a complex disease characterized by a mixture of inflammation
and fibrosis of the skin that, especially in the pediatric population, also affects …

[HTML][HTML] Morphea: progress to date and the road ahead

L Abbas, A Joseph, E Kunzler… - Annals of translational …, 2021 - ncbi.nlm.nih.gov
Morphea is a rare autoimmune condition causing inflammation and sclerosis of the skin and
underlying soft tissue. It is characterized by periods of activity (inflammation admixed with …

Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles

KS Torok, K Kurzinski, C Kelsey, J Yabes… - Seminars in arthritis and …, 2015 - Elsevier
Objective To evaluate peripheral blood T-helper (TH) cell-associated cytokine and
chemokine profiles in localized scleroderma (LS), and correlate them with clinical disease …

[HTML][HTML] Abatacept in the treatment of localized scleroderma: a pediatric case series and systematic literature review

I Kalampokis, YY Belina, AC Smidt - Seminars in Arthritis and Rheumatism, 2020 - Elsevier
Background Localized scleroderma (LS) is a rare chronic immune-mediated skin condition
of unknown etiology characterized by an inflammatory response in the skin and …

Elevated serum Interleukin‐23 levels in patients with oral and cutaneous lichen planus

M Mardani, H Mofidi, L Dastgheib… - Mediators of …, 2021 - Wiley Online Library
Lichen planus is considered a chronic inflammatory disease which affects different sites,
such as the skin, mucous membranes, hair, and nails. Based on the evidence, a complex …

High dietary salt intake activates inflammatory cascades via Th17 immune cells: impact on health and diseases

Y Balan, RM Packirisamy… - Archives of Medical …, 2020 - pmc.ncbi.nlm.nih.gov
The incidence of immune-mediated inflammatory diseases (IMIDs) is on the rise. A high salt
content in the diet was found to play a crucial role in mediating IMIDs. It was demonstrated …

Early-and late-stage morphea subtypes with deep tissue involvement is treatable with Abatacept (Orencia)

F Adeeb, S Anjum, P Hodnett, A Kashif, M Brady… - Seminars in Arthritis and …, 2017 - Elsevier
Objectives This case series explores the potential efficacy of Abatacept in patients
presenting with morphea subtypes and deep tissue involvement. Methods Three patients …

Immunologic underpinnings and treatment of morphea

AH LaChance, N Goldman, B Kassamali… - Expert Review of …, 2022 - Taylor & Francis
Introduction Morphea is a chronic autoimmune fibrosing condition of the skin and underlying
tissue with the potential for significant disease-associated morbidity. While the exact etiology …